At the intersection of virology, immunology, and oncology, we investigate the immune mechanisms driving HIV pathogenesis, cancer progression, and lymphatic dysfunction. Our translational research advances toward curative therapies and novel interventions.
Our laboratory pursues fundamental and translational research across multiple disease areas, exploring the immune system's role in health and disease.
Investigating viral reservoirs, latency mechanisms, and novel curative strategies
Understanding tumor-immune interactions and developing immunotherapeutic approaches
Exploring lymphatic dysfunction in disease and its therapeutic potential
Examining HIV's impact on brain health and neurocognitive function
Studying immune senescence and age-related disease susceptibility
Investigating epigenetic regulation of immune responses and viral latency
Our HIV cure research program is dedicated to understanding and eliminating viral reservoirs that persist despite antiretroviral therapy. We employ cutting-edge approaches to characterize latent HIV infection and develop strategies for viral eradication.
Our research directly informs clinical trials and therapeutic development, with several ongoing collaborations translating laboratory discoveries into patient care.
Our cancer immunology program investigates how the immune system recognizes and responds to malignant cells, with emphasis on developing novel immunotherapeutic strategies.
We aim to bring our discoveries from bench to bedside, focusing on cancers with unmet therapeutic needs.
The lymphatic system plays critical roles in immunity, fluid homeostasis, and disease pathogenesis. Our research explores lymphatic dysfunction in various disease contexts.
Our findings are informing new approaches to treating lymphatic disorders and preventing disease spread through lymphatic channels.
Despite effective antiretroviral therapy, many people with HIV experience neurocognitive impairment. Our program investigates the mechanisms underlying HIV-associated brain pathology.
Our research aims to develop interventions that preserve cognitive function and improve quality of life for people living with HIV.
Our aging research program examines how the immune system changes with age and chronic infection, leading to increased disease susceptibility and reduced vaccine responses.
Understanding immune aging has broad implications for managing chronic diseases and improving healthy lifespan.
Epigenetic modifications play crucial roles in immune cell function and viral latency. Our program uses cutting-edge single-cell and epigenomic approaches to understand gene regulation in disease.
We employ state-of-the-art technologies including ATAC-seq, ChIP-seq, and single-cell multi-omics to map the epigenetic landscape of disease.
Our multidisciplinary team brings together expertise in immunology, virology, computational biology, and clinical research.
Our research is published in leading scientific journals. Filter by research area below.
We welcome inquiries from prospective students, postdocs, and collaborators.
Weill Cornell Medicine
Division of Infectious Diseases
423st 69th Street
New York, NY 10065
Map placeholder